SUDEEPPHRM
SUDEEP PHARMA LIMITED
Each stock's 10,000-path forecast, rendered as light.
SUDEEP PHARMA LIMITED (SUDEEPPHRM) Stock Analysis & Case Study
Is SUDEEPPHRM a good buy? The data-driven verdict.
on the numbers it mixed signals, a Downstox Snapshot Score of 45/100.
On the numbers, SUDEEP PHARMA LIMITED (SUDEEPPHRM) mixed signals, a Downstox Snapshot Score of 45/100, weighing a 54% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
SUDEEPPHRM share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 0.6y of SUDEEPPHRM history (16%/yr drift, 46%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| SUDEEPPHRM 2027 | ₹493 | ₹885 | ₹1,598 | +5% |
| SUDEEPPHRM 2028 | ₹407 | ₹919 | ₹2,149 | +9% |
| SUDEEPPHRM 2029 | ₹352 | ₹987 | ₹2,712 | +17% |
| SUDEEPPHRM 2030 | ₹323 | ₹1,021 | ₹3,349 | +21% |
| SUDEEPPHRM 2031 | ₹297 | ₹1,081 | ₹3,958 | +28% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability SUDEEPPHRM goes up, or doubles?
The bull case for SUDEEPPHRM
- SUDEEP PHARMA LIMITED is part of the NSE universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹2,712.
The bear case & risks
- High historical volatility (46%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹352.
SUDEEPPHRM volatility & expected range, how bumpy is the ride?
Over the last 0.6 years SUDEEPPHRM compounded at 16%/year with annualized volatility of 46%. That volatility implies a 1-year 80% range of ₹493–₹1,598, the honest backbone behind any single price target.
SUDEEPPHRM price forecast, the full 60-month probability fan
SUDEEPPHRM price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds SUDEEPPHRM hits common targets within the simulated horizon?
Full multi-horizon detail on the SUDEEPPHRM price target & forecast page.
SUDEEPPHRM MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy SUDEEPPHRM with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.0% | 2.9× |
| ZerodhaCHEAPEST | 30.6% | 3.3× |
| DhanCHEAPEST | 30.6% | 3.3× |
Compare every broker on the SUDEEPPHRM MTF page.
SUDEEPPHRM vs peers,sector comparison
About SUDEEP PHARMA LIMITED: sector, index & market-cap context
SUDEEP PHARMA LIMITED (SUDEEPPHRM) is an NSE-listed company.
How the SUDEEPPHRM Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of SUDEEP PHARMA LIMITED's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
SUDEEPPHRM analysis, FAQs
Is SUDEEP PHARMA LIMITED (SUDEEPPHRM) a good buy?
On the numbers, SUDEEP PHARMA LIMITED (SUDEEPPHRM) mixed signals, a Downstox Snapshot Score of 45/100, weighing a 54% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is SUDEEPPHRM overvalued or undervalued?
Valuation ratios for SUDEEPPHRM are tracked live on Downstox.
What is the SUDEEPPHRM share price target for 2031?
SUDEEPPHRM's probability-weighted 2031 median target is ₹1,081, with an 80% range of ₹297–₹3,958 (10,000-path Monte-Carlo).
What is the probability SUDEEPPHRM doubles in 5 years?
The modelled probability of SUDEEPPHRM reaching ₹1,686 (2×) within 5 years is 33%.
What is the bull case for SUDEEPPHRM?
SUDEEP PHARMA LIMITED is part of the NSE universe with live, tracked fundamentals on Downstox.
What are the risks in SUDEEPPHRM?
High historical volatility (46%/yr) means a wide, bumpy range of outcomes, size positions accordingly.